Xylem Inc. (NYSE:XYL) was downgraded by Boenning Scattergood from an “outperform” rating to a “neutral” rating in a research report issued on Monday.

Several other research analysts have also weighed in on the company. Oppenheimer Holdings Inc. reaffirmed an “outperform” rating and issued a $58.00 target price (up from $55.00) on shares of Xylem in a research report on Monday, November 21st. Northcoast Research initiated coverage on Xylem in a research report on Thursday, November 17th. They issued a “buy” rating on the stock. Stifel Nicolaus increased their price objective on Xylem from $47.00 to $48.00 and gave the company a “hold” rating in a report on Wednesday, November 2nd. Janney Montgomery Scott raised Xylem from a “neutral” rating to a “buy” rating and increased their price objective for the company from $50.00 to $52.00 in a report on Wednesday, November 2nd. Finally, Atlantic Securities raised Xylem from a “neutral” rating to an “overweight” rating and set a $54.00 price objective on the stock in a report on Monday, August 22nd. Eight equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. Xylem presently has an average rating of “Buy” and a consensus target price of $47.15.

Analyst Recommendations for Xylem (NYSE:XYL)

Shares of Xylem (NYSE:XYL) opened at 52.92 on Monday. The company has a market capitalization of $9.49 billion, a P/E ratio of 29.37 and a beta of 1.18. The stock has a 50 day moving average price of $50.29 and a 200-day moving average price of $48.28. Xylem has a one year low of $31.67 and a one year high of $54.99.

Xylem (NYSE:XYL) last issued its earnings results on Tuesday, November 1st. The company reported $0.54 earnings per share for the quarter, topping the consensus estimate of $0.53 by $0.01. Xylem had a return on equity of 16.38% and a net margin of 8.83%. The company had revenue of $897 million for the quarter, compared to analyst estimates of $913.53 million. During the same period in the prior year, the firm posted $0.49 EPS. The business’s revenue was down .6% compared to the same quarter last year. Equities research analysts predict that Xylem will post $2.04 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Wednesday, December 7th. Stockholders of record on Wednesday, November 9th will be given a $0.1549 dividend. The ex-dividend date is Monday, November 7th. This represents a $0.62 annualized dividend and a dividend yield of 1.17%. Xylem’s dividend payout ratio is currently 34.44%.

WARNING: This piece of content was originally reported by The Cerbat Gem and is the propert of of The Cerbat Gem. If you are viewing this piece of content on another site, it was illegally stolen and republished in violation of US and international trademark and copyright legislation. The original version of this piece of content can be accessed at https://www.thecerbatgem.com/2016/11/28/xylem-inc-xyl-receives-neutral-rating-from-boenning-scattergood.html.

In other news, insider Colin R. Sabol sold 27,473 shares of the business’s stock in a transaction dated Thursday, September 8th. The stock was sold at an average price of $50.91, for a total value of $1,398,650.43. Following the sale, the insider now directly owns 65,530 shares in the company, valued at $3,336,132.30. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, SVP Claudia S. Toussaint sold 5,300 shares of Xylem stock in a transaction dated Friday, November 4th. The shares were sold at an average price of $47.27, for a total value of $250,531.00. Following the completion of the sale, the senior vice president now directly owns 44,033 shares in the company, valued at approximately $2,081,439.91. The disclosure for this sale can be found here. 0.77% of the stock is owned by insiders.

Several hedge funds have recently added to or reduced their stakes in XYL. Advisor Group Inc. bought a new stake in Xylem during the second quarter worth about $100,000. Mizuho Asset Management Co. Ltd. increased its position in shares of Xylem by 122.1% in the second quarter. Mizuho Asset Management Co. Ltd. now owns 2,323 shares of the company’s stock worth $104,000 after buying an additional 1,277 shares during the period. IFP Advisors Inc increased its position in shares of Xylem by 113.6% in the second quarter. IFP Advisors Inc now owns 2,489 shares of the company’s stock worth $111,000 after buying an additional 1,324 shares during the period. Northwestern Mutual Wealth Management Co. increased its position in shares of Xylem by 41.2% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 2,699 shares of the company’s stock worth $120,000 after buying an additional 788 shares during the period. Finally, Glenmede Trust Co. NA increased its position in shares of Xylem by 9.4% in the second quarter. Glenmede Trust Co. NA now owns 2,908 shares of the company’s stock worth $129,000 after buying an additional 250 shares during the period. 86.38% of the stock is currently owned by institutional investors and hedge funds.

About Xylem

Xylem Inc is engaged in the design, manufacturing, and application of engineered technologies for the water industry. The Company is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.

5 Day Chart for NYSE:XYL

Receive News & Stock Ratings for Xylem Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem Inc. and related stocks with our FREE daily email newsletter.